Table 1.
Polyphenol or Polyphenol Class | Oral Bioavailability | Main Cytochrome Interactions | Polyphenol-Polyphenol Interaction | Nutrients Interaction |
---|---|---|---|---|
Anthocyanidins | 1–2% [22] | Weak CYP450 inhibitors [60] | Not known | Lipids, carotenoids, digestible carbohydrates, hydrophilic and lipophilic vitamins, alkaloids, P-glycoprotein inhibitors improve flavonoids and curcumin bioavailability Minerals, proteins and dietary fibers decrease flavonoids bioavailability [38] |
Curcumin | <1% [61] | CYP3A4 (inhibition) [38] |
Not known | |
Flavan-3-ols | 2–15% in green tea; 5–10% in cocoa beans [26,27] | EGCG: inhibition of the activity of CYP1A2 CYP3A4 CYP2E1 [46] |
Green, black and oolong tea phenolic complex improve EGCG bioavailability [45] | |
Hydroxytyrosol | High [62] | Plausible interaction with CYP450 [62] | In olive oil tyrosol is converted in hydroxytyrosol by CYP2A6 and CYP2D6 [42,43] | |
Isoflavones | High [63] | Genistein: CYP450 ω-hydroxylase subfamily inhibitor [60] | Not known | |
Quercetin | <1% (up to 17% when ingested as glycoside) [64] | CYP1A2 CYP2A6 (inhibition) [65] |
Not known | |
Resveratrol | <1% [37] | CYP3A4 CYP1B1 CYP1A1 CYP1A2 (inhibition) [31,37,51] |
Red wine phenolic complex improves resveratrol bioavailability [35,37] Quercetin improves resveratrol bioavailability [40,41] |